Dr. Omer Shahab, MD

Dr. Shahab practices at Mary Washington Hospital in Fredericksburg, Virginia, part of Mary Washington Healthcare.

Dr. Shahab's NPI, 1750739009, was assigned on May 27, 2016. Dr. Shahab holds Virginia license 0101265214.

Dr. Shahab's primary practice is Mary Washington Hospital, at 1001 Sam Perry Boulevard, Fredericksburg, VA 22401 in Fredericksburg City. The practice phone is (540) 741-1100.

Dr. Shahab's primary practice is Mary Washington Hospital in Fredericksburg, Virginia, part of Mary Washington Healthcare. Dr. Shahab is also affiliated with Inova Fairfax Hospital. The medical group on file is Mary Washington Healthcare. Dmand AI also links Dr. Shahab to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shahab practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Shahab's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Shahab is licensed in Virginia.

CMS data shows 235 Medicare services from Dr. Shahab across 8 procedure codes in 2024, for 197 Medicare patients. Medicare paid $31,825 for them.

CMS counts 197 Medicare patients who saw Dr. Shahab in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shahab's median patient age at 60, with 55% women.

In 2024, Dr. Shahab wrote 205 Medicare Part D claims for 100 patients. 85% of them were for generic drugs. CMS names the drug for 148 of them, across 6 drugs with 11 or more claims each, at $14,122 in total drug cost. In 2023, CMS named 113 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Shahab for performance year 2024, reported as part of a group. CMS lists Dr. Shahab as offering telehealth. CMS counts 50 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Shahab, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Shahab, published from 2012 to 2025. 2018 was the busiest year, with 2. Dr. Shahab has published most often in Hepatol Commun. Dr. Shahab's most frequent co-authors are Bara Ibrahim El Kurdi, MD, Mehmet Sayiner, MD and Aasma Shaukat, MD.

CMS Open Payments shows 198 general payments to Dr. Shahab from 30 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 84% of the total. Boston Scientific Corporation paid the most, $1,458.